XML 28 R15.htm IDEA: XBRL DOCUMENT v3.23.4
Financial instruments
3 Months Ended
Nov. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial instruments Financial instruments
The Company uses derivative instruments to hedge its exposure to market risks, including interest rate and currency risks, arising from operating and financing risks. The Company has non-U.S. dollar denominated net investments and uses foreign currency denominated financial instruments, specifically foreign currency derivatives and foreign currency denominated debt, to hedge its foreign currency risk.

The Company economically hedges a portion of its exposure to equity price risk related to its investment in Cencora through VPF derivative contracts.
The notional amounts and fair value of derivative instruments outstanding were as follows (in millions):

November 30, 2023Notional Fair
Value
Location in Consolidated Condensed Balance Sheets
Derivatives designated as hedges:
Foreign currency forwards$$— Other current assets
Cross currency interest rate swaps350 12 Other current assets
Cross currency interest rate swaps300 18 Other non-current assets
Foreign currency forwards778 Other current liabilities
Cross currency interest rate swaps101 Other current liabilities
Foreign currency forwards— Other non-current liabilities
Derivatives not designated as hedges:
Foreign currency forwards$352 $Other current assets
Total return swaps186 Other current assets
Foreign currency forwards3,454 19 Other current liabilities
Variable prepaid forward contracts 3,726 3,338 Other non-current liabilities

August 31, 2023NotionalFair
Value
Location in Consolidated Condensed Balance Sheets
Derivatives designated as hedges:
Foreign currency forwards$31 $Other current assets
Cross currency interest rate swaps650 28 Other non-current assets
Foreign currency forwards805 Other current liabilities
Cross currency interest rate swaps102 Other current liabilities
Foreign currency forwards— Other non-current liabilities
Derivatives not designated as hedges:
Foreign currency forwards$3,139 $Other current assets
Total return swaps168 Other current assets
Foreign currency forwards817 Other current liabilities
Total return swaps26 Other current liabilities
Variable prepaid forward contracts 3,195 2,548 Other non-current liabilities

Net investment hedges
The Company uses cross currency interest rate swaps and foreign currency forward contracts to hedge net investments in subsidiaries with non-U.S. dollar functional currencies. For qualifying net investment hedges, changes in the fair value of the derivatives are recorded in Cumulative translation adjustments within Accumulated other comprehensive loss in the Consolidated Condensed Balance Sheets.
Cash flow hedges
The Company may use foreign currency forwards and interest rate swaps to hedge the variability in forecasted transactions and cash flows of certain floating-rate debt. For qualifying cash flow hedges, changes in the fair value of the derivatives are recorded in Unrealized gain (loss) on cash flow hedges in Accumulated other comprehensive loss within the Consolidated Condensed Balance Sheets, and released to the Consolidated Condensed Statements of Earnings when the hedged cash flows affect earnings.
Derivatives not designated as hedges
The Company enters into derivative transactions that are not designated as accounting hedges. These derivative instruments are economic hedges of foreign currency risks and equity price risk. The Company also utilizes total return swaps to economically hedge variability in compensation charges related to certain deferred compensation obligations.
The Company entered into VPF transactions with third-party financial institutions and received upfront prepayments related to the forward sale of shares of Cencora common stock. The upfront prepayments are recorded within Other non-current liabilities in the Consolidated Condensed Balance Sheets as derivatives. The Company has pledged shares of Cencora common stock as collateral upon entering into the VPF transactions. The VPF transactions provide the Company with current liquidity while allowing it to maintain voting and dividend rights in the Cencora common stock, as well as the ability to participate in future stock price appreciation during the term of the contracts up to a cap price specified in the contracts. The VPF transactions are expected to settle per their respective forward settlement dates, at which time the Company will be obligated, unless it elects to settle otherwise as described below, to deliver the full number of shares of Cencora common stock specified in the contracts to settle the agreements. The Company may receive additional cash payments to be determined based on the price of the Cencora common stock at the forward settlement dates relative to the forward floor and cap price specified in the contracts. Subject to certain conditions, the Company may elect to net settle the contract by delivery of shares (or payment of the cash value thereof) in lieu of receiving any additional cash. The aggregate number of Cencora shares to be delivered in connection with the VPF transactions will not exceed the shares subject to forward sale.

The terms of the VPF transactions were as follows (in millions):
Transaction dateShares pledged and maximum shares subject to forward salePrepayment amountForward settlement date
May 11, 20234.6$644 Fourth quarter, fiscal 2025
June 15, 20232.2325Third quarter, fiscal 2025
August 3, 20235.3801First quarter, fiscal 2026
August 4, 20235.3797Third quarter, fiscal 2026
November 9, 20232.7424Fourth quarter, fiscal 2026
20.0$2,991 

The income (expenses) due to changes in fair value of derivative instruments were recognized in the Consolidated Condensed Statements of Earnings as follows (in millions):
  Three months ended November 30,
 Location in Consolidated Condensed Statements of Earnings20232022
Total return swapSelling, general and administrative expenses$(1)$
Foreign currency forwards
Other (expense) income, net 1
59 (18)
Variable prepaid forwardOther (expense) income, net(366)— 

1.Excludes remeasurement gains and losses on economically hedged assets and liabilities.

Derivatives credit risk
Counterparties to derivative financial instruments expose the Company to credit-related losses in the event of counterparty nonperformance, and the Company regularly monitors the credit worthiness of each counterparty. The Company and its counterparties are subject to collateral requirements for certain derivative instruments which mitigates credit risk for both parties.

Derivatives offsetting
The Company does not offset the fair value amounts of derivative instruments subject to master netting agreements in the Consolidated Condensed Balance Sheets.